Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Chong, S.-A.
and
Remington, G.
1998.
Ethnicity and clozapine metabolism.
British Journal of Psychiatry,
Vol. 172,
Issue. 1,
p.
97.
Sloan, Darina
and
O'Boyle, James
1998.
RE: Clozapine-fluoxetine and the CYP450 system.
Irish Journal of Psychological Medicine,
Vol. 15,
Issue. 3,
p.
112.
Dauer, William T
Fahn, Stanley
and
Burke, Robert E
1998.
The Diagnosis and Treatment of Tardive Disorders.
Medical Update for Psychiatrists,
Vol. 3,
Issue. 4,
p.
119.
1998.
Letters to the Editor.
The Canadian Journal of Psychiatry,
Vol. 43,
Issue. 8,
p.
853.
Retz, W.
and
Rösler, M.
1999.
Leponex.
p.
1.
Monaco, Francesco
and
Cicolin, Alessandro
1999.
Interactions Between Anticonvulsant and Psychoactive Drugs.
Epilepsia,
Vol. 40,
Issue. s10,
Carvajal, Alfonso
and
Martín Arias, Luis H.
1999.
Vol. 22,
Issue. ,
p.
45.
Prior, Trevor I
Chue, Pierre S
Tibbo, Philip
and
Baker, Glen B
1999.
Drug metabolism and atypical antipsychotics.
European Neuropsychopharmacology,
Vol. 9,
Issue. 4,
p.
301.
Degner, D.
Adler, L.
Müller, P.
and
Rüther, E.
1999.
Leponex.
p.
120.
Özdemir, Vura
Masellis, Mario
Basile, Vincenzo S.
Kalow, Werner
Meltzer, Herbert Y.
Lieberman, Jeffrey A.
and
Kennedy, James L.
1999.
Variability in Response to Clozapine: Potential Role of Cytochrome P450 1A2 and the Dopamine D4Receptor Gene.
CNS Spectrums,
Vol. 4,
Issue. 6,
p.
30.
Hiemke, Christoph
and
Härtter, Sebastian
2000.
Pharmacokinetics of selective serotonin reuptake inhibitors.
Pharmacology & Therapeutics,
Vol. 85,
Issue. 1,
p.
11.
Allen, Sharon A.
2000.
Effect of Chlorpromazine and Clozapine on Plasma Concentrations of Haloperidol in a Patient with Schizophrenia.
The Journal of Clinical Pharmacology,
Vol. 40,
Issue. 11,
p.
1296.
Uges, Donald R. A.
Boom, Katja
Wientjes, Gijs D.
and
Versteege, John
2000.
Therapeutic Drug Monitoring of Clozapine: An Unexpected Outcome.
Therapeutic Drug Monitoring,
Vol. 22,
Issue. 3,
p.
323.
Masellis, Mario
Basile, Vincenzo S
Özdemir, Vural
Meltzer, Herbert Y
Macciardi, Fabio M
and
Kennedy, James L
2000.
Pharmacogenetics of antipsychotic treatment: lessons learned from clozapine.
Biological Psychiatry,
Vol. 47,
Issue. 3,
p.
252.
Burns, Michael J.
2001.
The Pharmacology and Toxicology of Atypical Antipsychotic Agents.
Journal of Toxicology: Clinical Toxicology,
Vol. 39,
Issue. 1,
p.
1.
Liu, Y. Y.
van Troostwijk, L. J. A. E. Doude
and
Guchelaar, H.‐J.
2001.
Simultaneous determination of clozapine, norclozapine and clozapine‐N‐oxide in human plasma by high‐performance liquid chromatography with ultraviolet detection.
Biomedical Chromatography,
Vol. 15,
Issue. 4,
p.
280.
Lane,, H.-Y.
Chiu,, C.C.
Kazmi,, Y.
Desai,, H.
Lam,, Y.W.F.
Jann,, M. W.
and
Chang,, W.-H.
2001.
Lack of CYP3A4 Inhibition by Grapefruit Juice and Ketoconazole upon Clozapine Administration in Vivo.
Drug Metabolism and Drug Interactions,
Vol. 18,
Issue. 3-4,
p.
263.
Burns, T.
Chabannes, J. P.
and
Demyttenaere, K.
2002.
Switching Antipsychotic Medications: General Recommendations and Switching to Amisulpride.
Current Medical Research and Opinion,
Vol. 18,
Issue. 4,
p.
201.
Langosch, J. M.
and
Trimble, M. R.
2002.
Epilepsy, psychosis and clozapine.
Human Psychopharmacology: Clinical and Experimental,
Vol. 17,
Issue. 2,
p.
115.
Zaccara, Gaetano
and
Cornaggia, Cesare Maria
2002.
The Use of Antidepressant and Antipsychotic Drugs in Elderly Epilepsy Patients.
Epilepsia,
Vol. 43,
Issue. s2,
p.
32.
eLetters
No eLetters have been published for this article.